Momeneh Foroutan

8PUBLICATIONS
46CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 05, 2024
IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development.

Wilford Goh, Harrison Sudholz, Momeneh Foroutan

|Apr 29, 2023
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.

Agustin Sgro, Joseph Cursons, Charlene Waryah

|Jun 27, 2022
TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity.

Fernando Souza-Fonseca-Guimaraes, Gustavo R Rossi, Laura F Dagley

|Apr 19, 2022
Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in "Cold" Melanoma.

Saketh S Dinavahi, Yu-Chi Chen, Kishore Punnath

|Aug 20, 2021
The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome.

Momeneh Foroutan, Ramyar Molania, Aline Pfefferle

|Mar 26, 2021
CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.

Anderly C Chüeh, Gahana Advani, Momeneh Foroutan

Pageof 2

Frequent Collaborators

5 joint publications

Joseph Cursons

5 joint publications

Nicholas D Huntington

3 joint publications

Melissa J Davis

3 joint publications

Soroor Hediyeh-Zadeh